VascVersa is a regenerative medicine company, seeking to deliver a new, exciting cell therapy to treat ischaemic diseases and promote rapid wound repair.
Thanks to our wonderful scientist Stuart McKeown who represented VascVersa at the recent Unistem2023 event. Special thanks to the @MedinaReinhold and QUB researchers for the opportunity.
Delighted to represent Northern Ireland ATN by chairing the panel discussion at the UKAT Roadshow event in Edinburgh this week. Thanks to our fabulous panel! Great discussions & fantastic science showcasing the vast potential of Advanced Therapies being developed in the UK!
Exciting news on completion of our second funding round- a major milestone for VascVersa. Special thanks to our funders @CoFundNI, @QubisLtd , @Innovation Investment Fund & @HBAN. Delighted to be working with this fantastic team! https://t.co/Ip4iNHsPHT
Exciting news on successful completion of our first funding round- a major milestone for VascVersa! Special thanks to @QubisLtd, @CoFundNI and @HBAN. Delighted to be working with @aidan_courtney and this fantastic team.
https://t.co/qyyWO6vPRr